Document is current
Any future updates will be listed below
-
Authors
Póvoa, Pedro http://orcid.org/0000-0002-7069-7304
Coelho, Luís http://orcid.org/0000-0003-0701-3624
Dal-Pizzol, Felipe http://orcid.org/0000-0003-3003-8977
Ferrer, Ricard http://orcid.org/0000-0002-4859-4747
Huttner, Angela http://orcid.org/0000-0002-8380-368X
Conway Morris, Andrew http://orcid.org/0000-0002-3211-3216
Nobre, Vandack http://orcid.org/0000-0002-7922-0422
Ramirez, Paula http://orcid.org/0000-0002-7598-3350
Rouze, Anahita http://orcid.org/0000-0002-1330-3161
Salluh, Jorge http://orcid.org/0000-0002-8164-1453
Singer, Mervyn http://orcid.org/0000-0002-1042-6350
Sweeney, Daniel A. http://orcid.org/0000-0002-5398-3528
Torres, Antoni http://orcid.org/0000-0002-8643-2167
Waterer, Grant http://orcid.org/0000-0002-7222-8018
Kalil, Andre C. http://orcid.org/0000-0002-6489-6294
- License Information
-
More Information
Article History
Received: 16 July 2022
Accepted: 8 December 2022
First Online: 2 January 2023
Declarations
:
: PP received fees for a lecture from Gilead, Pfizer and Mundipharma, consulting from MSD and Sanofi, and an unrestricted research grant from Abionic. AR received fess for lectures from MSD. ACM received fees for lectures from Boston Scientific and consulting from Cambridge Infection Diagnostics, is supported by a Clinician Scientist Fellowship from the Medical Research Council (MR/V006118/1). MS received fees for lectures at educational meetings for Biomerieux and Radiometer, consulting from Abbott, Biomerieux, deePull, Roche Diagnostics, Safeguard Biosystems and Spiden and performed preclinical and clinical research studies with Biomerieux, Cornel Scientific, DSTL (UK Ministry of Defence), Gentian. RF received fees for lectures, speakers’ bureaus or advisory boards from Grifols, MSD, Pfizer, Gilead, Shionogi, Thermofisher, Hill Rom, AOP Health and BD. LC, FD-P, AH, AK, VN, JS, PR, DS, GW, AT declare no conflict of interest.
Free to read: This content has been made available to all.
